CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage
Open Access
- 17 May 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 26239
Abstract
Paeoniflorin-6′-O-benzene sulfonate (code: CP-25), a novel ester derivative of paeoniflorin (Pae), was evaluated in rats with adjuvant-induced arthritis (AA) to study its potential anti-arthritic activity. AA rats were treated with CP-25 (25, 50, or 100 mg/kg) from days 17 to 29 after immunization. CP-25 effectively reduced clinical and histopathological scores compared with the AA groups. CP-25-treated rats exhibited decreases in pro-inflammatory cytokines (IL-1β, IL-6, IL-17 and TNF-α) coupled with an increase in the anti-inflammatory cytokine TGF-β1 in the serum. CP-25 treatment inhibited M1 macrophage activation and enhanced M2 macrophage activation by influencing cytokine production. Decreases in Th17-IL-17 and the Th17-associated transcription factor RAR-related orphan receptor gamma (ROR-γt) dramatically demonstrated the immunomodulatory effects of CP-25 on abnormal immune dysfunction. In addition, CP-25 suppressed the production of receptor activator of nuclear factor kappa B ligand (RANKL) and matrix metalloproteinase (MMP) 9, which supported its anti-osteoclastic effects. The data presented here demonstrated that CP-25 significantly inhibited the progression of rat AA by reducing inflammation, immunity and bone damage. The protective effects of CP-25 in AA highlight its potential as an ideal new anti-arthritic agent for human RA.Keywords
This publication has 58 references indexed in Scilit:
- Pharmacokinetics of paeoniflorin microemulsion after repeated dosing in rats with adjuvant arthritisDie Pharmazie, 2012
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid ArthritisNew England Journal of Medicine, 2012
- Paeoniflorin inhibits function of synoviocytes pretreated by rIL-1α and regulates EP4 receptor expressionJournal of Ethnopharmacology, 2011
- The dynamics of macrophage lineage populations in inflammatory and autoimmune diseasesArthritis & Rheumatism, 2009
- Evidence that cytokines play a role in rheumatoid arthritisJournal of Clinical Investigation, 2008
- Leptin Induces CD40 Expression through the Activation of Akt in Murine Dendritic CellsJournal of Biological Chemistry, 2007
- Paeoniflorin induced immune tolerance of mesenteric lymph node lymphocytes via enhancing beta 2-adrenergic receptor desensitization in rats with adjuvant arthritisInternational Immunopharmacology, 2007
- RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiationExperimental Cell Research, 2007
- Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destructionJournal of Experimental Medicine, 2006
- Rheumatic diseases: the effects of inflammation on boneImmunological Reviews, 2005